Drug Development

PRESS RELEASE - Washington D.C. - April 3, 2023 Genoskin and PharmaJet announce strategic research partnership to advance precision vaccine delivery Washington D.C., April 3, 2023 - Genoskin, a leading Franco-American TechBio company specializing in bio-stabilized immunocompetent human skin platforms, and PharmaJet, an innovative provider of Precision Delivery Systems (PDS), announce a strategic research partnership during the World Vaccine Congress.Read more

Top-level science through the eyes of an expert.The fourth Webinar. This webinar episode is open to English-speaking participants with a solid scientific background. Featured speaker is Dr. Behazine Combadière, PhD, the Global Head of Preclinical and Human Immunology at the R&D Vaccines Department of Sanofi. watch the replay In this webinar, Dr. Combadière will focus on the science behind epidermalRead more

Top-level science through the eyes of an expert.The third Webinar. This webinar episode is open to English-speaking participants with a solid scientific background. Featured speaker is nobody less than Dr. Itch himself, Dr. Brian Kim! watch the replay The ability to sense the environment is essential to survival and is the primary purpose of the somatosensory nervous system. However, despiteRead more

Human skin to better predict clinical trial outcomes Based on the Tech Nation interview with Dr. Eric Merle, our Chief Bussiness Innovation Officer by Moira Gunn, in February 2022. The entire Tech Nation Radio Podcast is available here. Eric's interview starts at 44:00 mins. Close is not good enough We've grown used to testing drugs in animals because some animalsRead more

Before proceeding to clinical trials in humans, today’s scientists study drug efficacy and toxicity in animals. Even though animal studies clearly raise ethical questions, it is considered even more unethical to conduct studies directly on humans without prior testing. Genoskin provides a unique alternative to animal testing and to human trials, using real, immunocompetent human skin. Why human skin isRead more

Advancing New Approach Methodologies for ethical & reliable drug development New Approach Methodologies: Changing drug development as we know it Drug development is long, expensive, and painfully inefficient. With 90% of drug candidates failing before clinical approval, the industry is desperate for human-relevant, predictive tools—this is where New Approach Methodologies (NAMs) have emerged as a vital solution. At Genoskin, weRead more